Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study.
Matilde SlotThomas Bøjer RasmussenMette NørgaardCarsten Schade LarsenLars Holger EhlersPublished in: PharmacoEconomics - open (2024)
The introduction and implementation of HAART in Danish healthcare was cost-effective, and in some scenarios, even disruptive, i.e., led to both cheaper and more effective care of PLHIV.